Review ArticleREVIEWS AND CONTEMPORARY UPDATES
Open Access

Current Approaches to Risk Assessment and Prevention of Preterm Birth—A Continuing Public Health Crisis

Joseph R. Biggio
Ochsner Journal December 2020, 20 (4) 426-433; DOI: https://doi.org/10.31486/toj.20.0005

REFERENCES

  1. 1.↵
    1. Blencowe H,
    2. Cousens S,
    3. Oestergaard MZ,
    4. et al.
    National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012 Jun 9;379(9832):2162-2172. doi: 10.1016/S0140-6736(12)60820-4.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.
    1. Frey HA,
    2. Klebanoff MA
    . The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 2016 Apr;21(2):68-73. doi: 10.1016/j.siny.2015.12.011.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Purisch SE,
    2. Gyamfi-Bannerman C.
    Epidemiology of preterm birth. Semin Perinatol. 2017 Nov;41(7):387-391. doi: 10.1053/j.semperi.2017.07.009.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Goldenberg RL,
    2. Culhane JF,
    3. Iams JD,
    4. Romero R
    . Epidemiology and causes of preterm birth. Lancet. 2008 Jan 5;371(9606):75-84. doi: 10.1016/S0140-6736(08)60074-4.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.
    1. Gyamfi-Bannerman C,
    2. Ananth CV
    . Trends in spontaneous and indicated preterm delivery among singleton gestations in the United States, 2005-2012. Obstet Gynecol. 2014 Dec;124(6):1069-1074. doi: 10.1097/AOG.0000000000000546.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Martin JA,
    2. Hamilton BE,
    3. Osterman MJK,
    4. Driscoll AK,
    5. Drake P
    . Births: final data for 2017. Natl Vital Stat Rep. 2018 Nov;67(8):1-50.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Martin JA,
    2. Hamilton BE,
    3. Osterman MJK,
    4. Driscoll AK,
    5. Drake P
    . Births: final data for 2016. Natl Vital Stat Rep. 2018 Jan;67(1):1-55.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Adams MM,
    2. Elam-Evans LD,
    3. Wilson HG,
    4. Gilbertz DA
    . Rates of and factors associated with recurrence of preterm delivery. JAMA. 2000 Mar 22-29;283(12):1591-1596. doi: 10.1001/jama.283.12.1591.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.
    1. Ananth CV,
    2. Getahun D,
    3. Peltier MR,
    4. Salihu HM,
    5. Vintzileos AM
    . Recurrence of spontaneous versus medically indicated preterm birth. Am J Obstet Gynecol. 2006 Sep;195(3):643-650. doi: 10.1016/j.ajog.2006.05.022.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Petrini JR,
    2. Callaghan WM,
    3. Klebanoff M,
    4. et al.
    Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol. 2005 Feb;105(2):267-272. doi: 10.1097/01.AOG.0000150560.24297.4f.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Edlow AG,
    2. Srinivas SK,
    3. Elovitz MA
    . Second-trimester loss and subsequent pregnancy outcomes: what is the real risk? Am J Obstet Gynecol. 2007 Dec;197(6):581.e1-581.e6. doi: 10.1016/j.ajog.2007.09.016.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Goldenberg RL,
    2. Mayberry SK,
    3. Copper RL,
    4. Dubard MB,
    5. Hauth JC
    . Pregnancy outcome following a second-trimester loss. Obstet Gynecol. 1993 Mar;81(3):444-446.
    OpenUrlPubMedWeb of Science
  13. 13.↵
    1. Iams JD
    . Clinical practice. Prevention of preterm parturition. N Engl J Med. 2014 Jan 16;370(3):254-261. doi: 10.1056/NEJMcp1103640.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. McManemy J,
    2. Cooke E,
    3. Amon E,
    4. Leet T
    . Recurrence risk for preterm delivery. Am J Obstet Gynecol. 2007 Jun;196(6):576.e1-576.e6; discussion 576.e6-576.e7. doi: 10.1016/j.ajog.2007.01.039.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Kyrklund-Blomberg NB,
    2. Cnattingius S
    . Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol. 1998 Oct;179(4):1051-1055. doi: 10.1016/s0002-9378(98)70214-5.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.
    1. Meis PJ,
    2. Michielutte R,
    3. Peters TJ,
    4. et al.
    Factors associated with preterm birth in Cardiff, Wales. I. Univariable and multivariable analysis. Am J Obstet Gynecol. 1995 Aug;173(2):590-596. doi: 10.1016/0002-9378(95)90287-2.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.
    1. Saccone G,
    2. Perriera L,
    3. Berghella V
    . Prior uterine evacuation of pregnancy as independent risk factor for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016 May;214(5):572-591. doi: 10.1016/j.ajog.2015.12.044.
    OpenUrlCrossRefPubMed
  18. 18.
    1. Srinivasjois RM,
    2. Shah S
    , Shah PS; Knowledge Synthesis Group on Determinants Of Preterm/LBW Births. Biracial couples and adverse birth outcomes: a systematic review and meta-analyses. Acta Obstet Gynecol Scand. 2012 Oct;91(10):1134-1146. doi: 10.1111/j.1600-0412.2012.01501.x.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Wong LF,
    2. Wilkes J,
    3. Korgenski K,
    4. Varner MW,
    5. Manuck TA
    . Risk factors associated with preterm birth after a prior term delivery. BJOG. 2016 Oct;123(11):1772-1778. doi: 10.1111/1471-0528.13683.
    OpenUrlCrossRef
  20. 20.↵
    1. Porter TF,
    2. Fraser AM,
    3. Hunter CY,
    4. Ward RH,
    5. Varner MW
    . The risk of preterm birth across generations. Obstet Gynecol. 1997 Jul;90:63-67. doi: 10.1016/S0029-7844(97)00215-9.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Wilcox AJ,
    2. Skjaerven R,
    3. Lie RT
    . Familial patterns of preterm delivery: maternal and fetal contributions. Am J Epidemiol. 2008 Feb 15;167(4):474-479. doi: 10.1093/aje/kwm319.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Jones NM,
    2. Holzman C,
    3. Tian Y,
    4. et al.
    Innate immune system gene polymorphisms in maternal and child genotype and risk of preterm delivery. J Matern Fetal Neonatal Med. 2012 Mar;25(3):240-247. doi: 10.3109/14767058.2011.569614.
    OpenUrlCrossRefPubMed
  23. 23.
    1. Menon R,
    2. Pearce B,
    3. Velez DR,
    4. et al.
    Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod Biol Endocrinol. 2009 Jun 15;7:62. doi: 10.1186/1477-7827-7-62.
    OpenUrlCrossRefPubMed
  24. 24.
    1. Velez DR,
    2. Fortunato S,
    3. Thorsen P,
    4. Lombardi SJ,
    5. Williams SM,
    6. Menon R
    . Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants. Am J Obstet Gynecol. 2009 Feb;200(2):209.e1-209.e27. doi: 10.1016/j.ajog.2008.08.051.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Wu W,
    2. Clark EAS,
    3. Stoddard GJ,
    4. et al.
    Effect of interleukin-6 polymorphism on risk of preterm birth within population strata: a meta-analysis. BMC Genet. 2013 Apr 25;14:30. doi: 10.1186/1471-2156-14-30.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. To MS,
    2. Skentou CA,
    3. Royston P,
    4. Yu CKH,
    5. Nicolaides KH
    . Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol. 2006 Apr;27(4):362-367.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Esplin MS,
    2. Elovitz MA,
    3. Iams JD
    , et al; nuMoM2b Network. Predictive accuracy of serial transvaginal cervical lengths and quantitative vaginal fetal fibronectin levels for spontaneous preterm birth among nulliparous women. JAMA. 2017 Mar 14;317(10):1047-1056. doi: 10.1001/jama.2017.1373.
    OpenUrlCrossRef
  28. 28.↵
    1. Heath VC,
    2. Southall TR,
    3. Souka AP,
    4. Elisseou A,
    5. Nicolaides KH
    . Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 1998 Nov;12(5):312-317. doi: 10.1046/j.1469-0705.1998.12050312.x.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Iams JD,
    2. Goldenberg RL,
    3. Meis PJ,
    4. et al.
    The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996 Feb 29;334(9):567-572. doi: 10.1056/NEJM199602293340904.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Guzman ER,
    2. Walters C,
    3. Ananth CV,
    4. et al.
    A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations. Ultrasound Obstet Gynecol. 2001 Sep;18(3):204-210. doi: 10.1046/j.0960-7692.2001.00526.x.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.
    1. Iams JD,
    2. Goldenberg RL,
    3. Mercer BM
    , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The preterm prediction study: can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol. 2001 Mar;184(4):652-655. doi: 10.1067/mob.2001.111248.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Leung TN,
    2. Pang MW,
    3. Leung TY,
    4. Poon CF,
    5. Wong SM,
    6. Lau TK
    . Cervical length at 18-22 weeks of gestation for prediction of spontaneous preterm delivery in Hong Kong Chinese women. Ultrasound Obstet Gynecol. 2005 Dec;26(7):713-717. doi: 10.1002/uog.2617.
    OpenUrlCrossRefPubMed
  33. 33.↵
    Committee on Practice Bulletins—Obstetrics, The American College of Obstetricians and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol. 2012 Oct;120(4):964-973. doi: 10.1097/AOG.0b013e3182723b1b.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Fonseca EB,
    2. Celik E,
    3. Parra M,
    4. Singh M,
    5. Nicolaides KH
    ; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007 Aug 2;357(5):462-469. doi: 10.1056/NEJMoa067815.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Goya M,
    2. Pratcorona L,
    3. Merced C
    , et al; Pesario Cervical para Evitar Prematuridad (PECEP) Trial Group. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet. 2012 May 12;379(9828):1800-1806. doi: 10.1016/S0140-6736(12)60030-0.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Grobman WA,
    2. Thom EA,
    3. Spong CY
    , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol. 2012 Nov;207(5):390.e1-390.e8. doi: 10.1016/j.ajog.2012.09.013.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Hassan SS,
    2. Romero R,
    3. Vidyadhari D
    , et al; PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31. doi: 10.1002/uog.9017.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Romero R,
    2. Conde-Agudelo A,
    3. Da Fonseca E,
    4. et al.
    Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018 Feb;218(2):161-180. doi: 10.1016/j.ajog.2017.11.576.
    OpenUrlCrossRef
  39. 39.
    1. Romero R,
    2. Conde-Agudelo A,
    3. El-Refaie W,
    4. et al.
    Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data. Ultrasound Obstet Gynecol. 2017 Mar;49(3):303-314. doi: 10.1002/uog.17397.
    OpenUrlCrossRef
  40. 40.↵
    1. Romero R,
    2. Nicolaides K,
    3. Conde-Agudelo A,
    4. et al.
    Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012 Feb;206(2):124.e1-124.e19. doi: 10.1016/j.ajog.2011.12.003.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Pirjani R,
    2. Heidari R,
    3. Rahimi-Foroushani A,
    4. Bayesh S,
    5. Esmailzadeh A
    . 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: a randomized controlled trial. J Obstet Gynaecol Res. 2017 Jan;43(1):57-64. doi: 10.1111/jog.13151.
    OpenUrlCrossRef
  42. 42.↵
    1. Pustotina O
    . Effectiveness of dydrogesterone, 17-OH progesterone and micronized progesterone in prevention of preterm birth in women with a short cervix. J Matern Fetal Neonatal Med. 2018 Jul;31(14):1830-1838. doi: 10.1080/14767058.2017.1330406.
    OpenUrlCrossRef
  43. 43.↵
    1. Owen J,
    2. Iams JD,
    3. Hauth JC
    . Vaginal sonography and cervical incompetence. Am J Obstet Gynecol. 2003 Feb;188(2):586-596. doi: 10.1067/mob.2003.137.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Owen J,
    2. Hankins G,
    3. Iams JD,
    4. et al.
    Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol. 2009 Oct;201(4):375.e1-375.e8. doi: 10.1016/j.ajog.2009.08.015.
    OpenUrlCrossRefPubMed
  45. 45.
    1. Althuisius SM,
    2. Dekker GA,
    3. Hummel P,
    4. Bekedam DJ,
    5. van Geijn HP
    . Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol. 2001 Nov;185(5):1106-1112. doi: 10.1067/mob.2001.118655.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.
    1. Berghella V,
    2. Odibo AO,
    3. Tolosa JE
    . Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol. 2004 Oct;191(4):1311-1317. doi: 10.1016/j.ajog.2004.06.054.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.
    1. Rust OA,
    2. Atlas RO,
    3. Reed J,
    4. van Gaalen J,
    5. Balducci J
    . Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol. 2001 Nov;185(5):1098-1105. doi: 10.1067/mob.2001.118163.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. To MS,
    2. Alfirevic Z,
    3. Heath VCF
    , et al; Fetal Medicine Foundation Second Trimester Screening Group. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet. 2004 Jun 5;363(9424):1849-1853. doi: 10.1016/S0140-6736(04)16351-4.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    1. Berghella V,
    2. Ciardulli A,
    3. Rust OA,
    4. et al.
    Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017 Nov;50(5):569-577. doi: 10.1002/uog.17457.
    OpenUrlCrossRef
  50. 50.↵
    1. Enakpene CA,
    2. DiGiovanni L,
    3. Jones TN,
    4. Marshalla M,
    5. Mastrogiannis D,
    6. Della Torre M
    . Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening. Am J Obstet Gynecol. 2018 Oct;219(4):397.e1-397.e10. doi: 10.1016/j.ajog.2018.06.020.
    OpenUrlCrossRef
  51. 51.↵
    1. Abdel-Aleem H,
    2. Shaaban OM,
    3. Abdel-Aleem MA
    . Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev. 2013 May 31;2013(5):CD007873. doi: 10.1002/14651858.CD007873.pub3.
    OpenUrlCrossRef
  52. 52.↵
    1. Arabin B,
    2. Alfirevic Z.
    Cervical pessaries for prevention of spontaneous preterm birth: past, present and future. Ultrasound Obstet Gynecol. 2013 Oct;42(4):390-399. doi: 10.1002/uog.12540.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Nicolaides KH,
    2. Syngelaki A,
    3. Poon LC,
    4. et al.
    A randomized trial of a cervical pessary to prevent preterm singleton birth. N Engl J Med. 2016 Mar 17;374(11):1044-1052. doi: 10.1056/NEJMoa1511014.
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Saccone G,
    2. Maruotti GM,
    3. Giudicepietro A,
    4. Martinelli P
    ; Italian Preterm Birth Prevention (IPP) Working Group. Effect of cervical pessary on spontaneous preterm birth in women with singleton pregnancies and short cervical length: a randomized clinical trial. JAMA. 2017 Dec 19;318(23):2317-2324. doi: 10.1001/jama.2017.18956.
    OpenUrlCrossRef
  55. 55.↵
    1. Saccone G,
    2. Ciardulli A,
    3. Xodo S,
    4. et al.
    Cervical pessary for preventing preterm birth in singleton pregnancies with short cervical length: a systematic review and meta-analysis. J Ultrasound Med. 2017 Aug;36(8):1535-1543. doi: 10.7863/ultra.16.08054.
    OpenUrlCrossRef
  56. 56.↵
    1. Cetingoz E,
    2. Cam C,
    3. Sakallı M,
    4. Karateke A,
    5. Celik C,
    6. Sancak A
    . Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet. 2011 Mar;283(3):423-429. doi: 10.1007/s00404-009-1351-2.
    OpenUrlCrossRefPubMed
  57. 57.
    1. Norman JE,
    2. Marlow N,
    3. Messow CM
    , et al; OPPTIMUM study group. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet. 2016 May 21;387(10033):2106-2116.
    OpenUrlCrossRefPubMed
  58. 58.↵
    1. O'Brien JM,
    2. Adair CD,
    3. Lewis DF,
    4. et al.
    Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007 Oct;30(5):687-696. doi: 10.1002/uog.5158.
    OpenUrlCrossRefPubMedWeb of Science
  59. 59.↵
    1. Cahill AG,
    2. Odibo AO,
    3. Caughey AB,
    4. et al.
    Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol. 2010 Jun;202(6):548.e1-548.e8. doi: 10.1016/j.ajog.2009.12.005.
    OpenUrlCrossRefPubMed
  60. 60.
    1. Einerson BD,
    2. Grobman WA,
    3. Miller ES
    . Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. Am J Obstet Gynecol. 2016 Jul;215(1):100.e1-100.e7. doi: 10.1016/j.ajog.2016.01.192.
    OpenUrlCrossRef
  61. 61.↵
    1. Werner EF,
    2. Hamel MS,
    3. Orzechowski K,
    4. Berghella V,
    5. Thung SF
    . Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update. Am J Obstet Gynecol. 2015 Oct;213(4):554.e1-554.e6. doi: 10.1016/j.ajog.2015.06.020.
    OpenUrlCrossRef
  62. 62.↵
    Prometrium [package insert]. Marietta, GA: Solvay Pharmaceuticals, Inc; 2009. www.accessdata.fda.gov/drugsatfda_docs/label/2011/019781s017,020843s011lbl.pdf
  63. 63.↵
    Crinone [package insert]. Parsippany, NJ: Watson Pharma, Inc; 2013. www.accessdata.fda.gov/drugsatfda_docs/label/2013/020701s026lbl.pdf
  64. 64.↵
    1. Meis PJ,
    2. Klebanoff M,
    3. Thom E
    , et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003 Jun 12;348(24):2379-2385.
    OpenUrlCrossRefPubMedWeb of Science
  65. 65.↵
    1. Blackwell SC,
    2. Gyamfi-Bannerman C,
    3. Biggio JR Jr.,
    4. et al.
    PROLONG clinical study protocol: hydroxyprogesterone caproate to reduce recurrent preterm birth. Am J Perinatol. 2018 Oct;35(12):1228-1234. doi: 10.1055/s-0038-1642062.
    OpenUrlCrossRef
  66. 66.↵
    1. Blackwell SC,
    2. Gyamfi-Bannerman C,
    3. Biggio JR Jr.,
    4. et al.
    17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): a multicenter, international, randomized double-blind trial. Am J Perinatol. 2020 Jan;37(2):127-136. doi: 10.1055/s-0039-3400227.
    OpenUrlCrossRef
  67. 67.↵
    FDA advisory board votes to recommend withdrawing progesterone therapy for preterm birth. Pharmacy Times. October 30, 2019. www.pharmacytimes.com/news/fda-advisory-board-votes-to-recommend-withdrawing-progesterone-therapy-for-preterm-birth. Accessed October 22, 2020.
  68. 68.↵
    CDER proposes withdrawal of approval for Makena. U.S. Food and Drug Administration. www.fda.gov/drugs/drug-safety-and-availability/cder-proposes-withdrawal-approval-makena. Published October 5, 2020. Accessed October 22, 2020.
  69. 69.↵
    SMFM statement: use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth. Am J Obstet Gynecol. 2020 Jul;223(1):B16-B18. doi: 10.1016/j.ajog.2020.04.001.
    OpenUrlCrossRef
  70. 70.↵
    1. da Fonseca EB,
    2. Bittar RE,
    3. Carvalho MHB,
    4. Zugaib M
    . Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003 Feb;188(2):419-424. doi: 10.1067/mob.2003.41.
    OpenUrlCrossRefPubMedWeb of Science
  71. 71.↵
    1. Jarde A,
    2. Lutsiv O,
    3. Beyene J,
    4. McDonald SD
    . Vaginal progesterone, oral progesterone, 17-OHPC, cerclage, and pessary for preventing preterm birth in at-risk singleton pregnancies: an updated systematic review and network meta-analysis. BJOG. 2019 Apr;126(5):556-567. doi: 10.1111/1471-0528.15566.
    OpenUrlCrossRef
  72. 72.↵
    1. Hernandez-Andrade E,
    2. Romero R,
    3. Ahn H,
    4. et al.
    Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix. J Matern Fetal Neonatal Med. 2012 Sep;25(9):1682-1689. doi: 10.3109/14767058.2012.657278.
    OpenUrlCrossRefPubMed
  73. 73.↵
    1. Hibbard JU,
    2. Tart M,
    3. Moawad AH
    . Cervical length at 16-22 weeks' gestation and risk for preterm delivery. Obstet Gynecol. 2000 Dec;96(6):972-978. doi: 10.1016/s0029-7844(00)01074-7.
    OpenUrlCrossRefPubMedWeb of Science
  74. 74.↵
    1. McIntosh J,
    2. Feltovich H,
    3. Berghella V,
    4. Manuck T
    . The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol. 2016 Sep;215(3):B2-B7. doi: 10.1016/j.ajog.2016.04.027.
    OpenUrlCrossRefPubMed
  75. 75.↵
    1. Berghella V,
    2. Rafael TJ,
    3. Szychowski JM,
    4. Rust OA,
    5. Owen J
    . Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol. 2011 Mar;117(3):663-671. doi: 10.1097/aog.0b013e31820ca847.
    OpenUrlCrossRefPubMedWeb of Science
  76. 76.↵
    1. Berghella V,
    2. Haas S,
    3. Chervoneva I,
    4. Hyslop T
    . Patients with prior second-trimester loss: prophylactic cerclage or serial transvaginal sonograms? Am J Obstetr Gynecol. 2002 Sep;187(3):747-751. doi: 10.1067/mob.2002.124289.
    OpenUrlCrossRefPubMed
  77. 77.↵
    1. Mackeen AD,
    2. Rafael TJ,
    3. Zavodnick J,
    4. Berghella V
    . Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage. Am J Perinatol. 2013 Oct;30(9):755-758. doi: 10.1055/s-0032-1332799.
    OpenUrlCrossRef
  78. 78.↵
    1. Stetson B,
    2. Hibbard JU,
    3. Wilkins I,
    4. Leftwich H
    . Outcomes with cerclage alone compared with cerclage plus 17α-hydroxyprogesterone caproate. Obstet Gynecol. 2016 Nov;128(5):983-988. doi: 10.1097/AOG.0000000000001681.
    OpenUrlCrossRef
  79. 79.↵
    1. Szychowski JM,
    2. Berghella V,
    3. Owen J
    , et al; Vaginal Ultrasound Trial Consortium. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate. J Matern Fetal Neonatal Med. 2012 Dec;25(12):2686-2689. doi: 10.3109/14767058.2012.717128.
    OpenUrlCrossRef
  80. 80.↵
    1. Berghella V,
    2. Figueroa D,
    3. Szychowski JM
    , et al; Vaginal Ultrasound Trial Consortium. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior PTB and a short cervical length. Am J Obstet Gynecol. 2010 Apr;202(4):351.e1-351.e6. doi: 10.1016/j.ajog.2010.02.019.
    OpenUrlCrossRefPubMed
  81. 81.↵
    SMFM preterm birth toolkit. Society for Maternal-Fetal Medicine. www.smfm.org/publications/231-smfm-preterm-birth-toolkit. Published 2016. Accessed October 22, 2020.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords